Capricorn Fund Managers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Sell
22,130
-143,600
-87% -$3.76M 0.04% 152
2026
Q1
$4.65M Buy
165,730
+161
+0.1% +$4.29K 0.73% 46
2025
Q4
$4.12M Buy
+165,569
New +$4.18M 0.99% 38
2025
Q3
Sell
-188,699
Closed -$4.57M 72
2025
Q2
$4.57M Sell
188,699
-17,513
-8% -$408K 2.16% 22
2025
Q1
$5.23M Sell
206,212
-392
-0.2% -$10.3K 2.79% 15
2024
Q4
$5.46M Sell
206,604
-225
-0.1% -$6.1K 2.43% 14
2024
Q3
$5.99M Hold
206,829
4.03% 7
2024
Q2
$5.79M Hold
206,829
4.08% 5
2024
Q1
$5.74M Buy
206,829
+66,481
+47% +$1.84M 3.46% 7
2023
Q4
$4.04M Buy
+140,348
New +$4.24M 2.22% 15
2022
Q1
Sell
-9,189
Closed -$543K 108
2021
Q4
$543K Buy
+9,189
New +$455K 0.15% 68

Other funds holding PFE

Capricorn Fund Managers's PFE Position: Q2 2026 in Review

Capricorn Fund Managers reduced its Pfizer (PFE) stake by 87% in Q2 2026, selling an estimated $3.76M and leaving 22,130 shares worth $533K. The position accounts for 0.04% of the portfolio, ranked #152.

Capricorn Fund Managers first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $5.99M in Q3 2024. 1,440 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capricorn Fund Managers held 22,130 shares of Pfizer worth $533K as of Q2 2026.
  • Capricorn Fund Managers sold 143,600 Pfizer shares in Q2 2026, an estimated $3.76M.
  • Pfizer made up 0.04% of Capricorn Fund Managers's portfolio in Q2 2026, its #152 holding.
  • Capricorn Fund Managers first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
  • Capricorn Fund Managers's Pfizer position peaked at $5.99M in Q3 2024.
  • 1,440 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.